Segall Bryant & Hamill, LLC
- SEC CIK
- 0001006378
- Latest filing
- Aug 12, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Segall Bryant & Hamill, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −484,178−100.0% | Sold out | Holders |
| Q3 2023 | 484,178 | $46.9M | 0.5% | −4,094−0.8% | Reduced | Holders |
| Q2 2023 | 488,272 | $53.2M | 0.6% | −20,175−4.0% | Reduced | Holders |
| Q1 2023 | 508,447 | $51.5M | 0.6% | −4,882−1.0% | Reduced | Holders |
| Q4 2022 | 513,329 | $56.4M | 0.6% | −12,628−2.4% | Reduced | Holders |
| Q3 2022 | 525,957 | $50.9M | 0.6% | −11,652−2.2% | Reduced | Holders |
| Q2 2022 | 537,609 | $58.4M | 0.7% | −4,001−0.7% | Reduced | Holders |
| Q1 2022 | 541,610 | $64.2M | 0.6% | −2,787−0.5% | Reduced | Holders |
| Q4 2021 | 544,397 | $76.6M | 0.7% | −10,299−1.9% | Reduced | Holders |
| Q3 2021 | 554,696 | $65.6M | 0.6% | −1,134−0.2% | Reduced | Holders |
| Q2 2021 | 555,830 | $64.5M | 0.6% | −49,840−8.2% | Reduced | Holders |
| Q1 2021 | 605,670 | $72.6M | 0.7% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.